- California to award $111M for behavioral health supportive housing
- ‘It’s no longer a theory. It’s here’: Tampa General’s revenue cycle chief on the age of AI agents
- 6 new psychiatric residency programs to know
- 3 health systems recognized for cybersecurity results
- USOSM adds New York practice
- NAMI partners on health crisis preparation hub
- Sutter Health, NBA’s Kings ink jersey patch deal
- The ’10-5-2′ rule behind Scripps Health’s drop in workplace violence injuries
- CMS proposes nationwide joint replacement payment model
- FDA commissioner is out: 8 things to know
- Oklahoma enacts law expanding access to dental care
- 5 CFO job openings with HCA
- Federal subpoena seeks NYU Langone gender-affirming care records
- 300,000 in limbo as BCBS Michigan, Michigan Medicine clash over reimbursement
- Bon Secours breaks ground on $200M hospital expansion
- Mayo Clinic CEO to step down
- Where dentists are leaving value behind in practice sales
- Why dental practices are closing in 2026
- Texas dental school to launch master’s program with orthodontic specialty
- Ophthalmology MSO receives private equity investment
- Qualitas Dental Partners makes investments into 7 practices
- Spine device company CFO pleads guilty to kickback scheme
- OrthoCarolina to grow its ASC capacity by 150%
- 988 calls are rising — what’s behind the surge?
- Multidisciplinary GI clinic names new president, COO
- Providence hospital to lay off 40 workers amid behavioral health staffing overhaul
- The specialties ASCs are fighting hardest to recruit
- 600+ ASCs performing total joint replacements | 2026
- How AI can boost independent dentistry
- BioMarin consolidates staff at Amicus HQ after closing $4.8B deal for rare disease peer
- Texas behavioral health operator files for Chapter 11
- 12 hospitals, health systems investing in GI
- US Monitors For Hantavirus As WHO Expects More Cases But 'Not Another COVID'
- MultiCare pilot targets opioid overdoses with 5-day treatment
- Michigan sends 152 youths out of state for mental healthcare: Report
- The key to private practice success in dentistry
- 12 major hospital deals in 1 month
- Aspen Dental opens offices in Texas, Utah
- Tennessee enacts new noncompete restrictions
- The biggest threats to DSO growth in 2026
- 1 in 5 marketplace enrollees dropped their coverage in 2026: media report
- Hims & Hers posts $92M loss in Q1 as it shifts to branded GLP-1 medications
- Listen to the Latest ‘KFF Health News Minute’
- FDA Commissioner Marty Makary to resign, capping turbulent tenure: report
- FDA Commissioner Marty Makary to resign, capping turbulent tenure: report
- Providence puts years of losses in rearview with its third consecutive quarter of operating gains
- Millions of Women Suffer in Silence From Treatable Pelvic Organ Prolapse
- Eli Lilly pauses Indian obesity awareness campaign after regulatory notices: report
- Optum Rx unveils new transparent PBM model
- Fitness wearable Whoop adds on-demand clinician access, EHR syncing
- Alkermes’ Lumryz hits phase 3 mark in another sleep disorder, fueling momentum from $2.4B Avadel acquisition
- Bayer's Eylea declines by 24%, bearing the brunt of biosmilar competition
- Pfizer, Arvinas win $85M upfront in Rigel licensing pact for new breast cancer med Veppanu
- As public vaccine criticism quiets, RFK Jr. keeps safety inquiries running in background: NYT
- As public vaccine criticism quiets, RFK Jr. keeps safety inquiries running in background: NYT
- What's Fueling The High U.S. Death Rate? It Might Not Be What You Think
- Telemedicine Not Breaking The Bank, Also Not Expanding Patient Access
- After-School Sports An Overall Boon To Children And Teens, Study Shows
- Trump Promised Cheaper Drugs. Some Prices Dropped. Many Others Shot Up
- Why Are Older Adults Taking Edibles? Survey Reveals Some Surprises
- Low Wages, Empty Plates, Heavy Toll: Rethinking Suicide Prevention
- EU advances scheme to bolster manufacturing autonomy, avert drug shortages
- Bicara Therapeutics hires Replimune, Sanofi alum as chief commercial officer
- Henry Ford Health to receive $12M suicide prevention grant
- The broken pipeline of mental healthcare for LGBTQ teenagers
- Novant hospital’s pediatric behavioral ED stays drop from 6 weeks to 2.11 days
- FDA Launches One-Day Inspectional Assessments to Strengthen and Expand Oversight
- FDA Launches One-Day Inspectional Assessments to Strengthen and Expand Oversight
- Is your hospital ready for a prolonged IT outage? Joint Commission, AHA's new resiliency program will let you know
- FDA Expands AI Capabilities: Launches ELSA and Completes HALO Data Platform Consolidation
- FDA Expands AI Capabilities: Launches ELSA and Completes HALO Data Platform Consolidation
- Roche acquires PathAI to transform AI-driven diagnostics
- Roche acquires PathAI to transform AI-driven diagnostics
- Trump Planning to Fire FDA Commissioner Marty Makary
- Trump Planning to Fire FDA Commissioner Marty Makary
- Included Health launches AI-powered solution to connect members to providers
- FDA Green Lights Bizengri Drug To Treat Rare, Aggressive Bile Duct Cancer
- The Hidden Design Flaw in Medical Device Service Technology
- The Hidden Design Flaw in Medical Device Service Technology
- An Endovascular Approach to Neurological Diseases Can Shift the Treatment Paradigm
- An Endovascular Approach to Neurological Diseases Can Shift the Treatment Paradigm
- 8,500 Steps A Day Could Be Sweet Spot For Preventing Weight Regain
- Why Gen AI is a Win for MedTech: And, How to Unlock its Potential with the Right Policies
- Why Gen AI is a Win for MedTech: And, How to Unlock its Potential with the Right Policies
- Survey: Employers seeking greater transparency from pharmacy benefits
- Kaiser Permanente's investments pick up the slack as Q1 operating margin slims to 2.1%
- AMA unveils policy framework to combat AI deepfake physician impersonation
- The Medical Device Cybersecurity Gap Hiding in Plain Sight
- The Medical Device Cybersecurity Gap Hiding in Plain Sight
- CSL slashes revenue projection and takes $5B impairment as interim CEO flags R&D misses, market erosion
- Healthcare bankruptcies up 33% in Q1 2026: report
- Why Doctors Are Quitting At An Earlier Age
- Sharper Brains May Face Higher Depression Relapse Risk, Study Finds
- Older Adults Have Fewer Regrets, Study Says
- Partner's bispecific Bizengri nabs FDA national priority nod in rare bile duct cancer
- Daiichi Sankyo targets global top 5 oncology rank by 2035, $1.3B efficiency drive in new 5-year plan
- That Discount At The Pharmacy Counter May Pack Hidden Costs
- Nighttime Heat Waves Increase Asthma Risk
- As Ranks of Uninsured Grow, Minnesota’s Hospitals Are Among Least Charitable in Nation
- Watch: 8 Health Insurance Terms You Should Know
- OVID Health hires Edelman alum Davide Scalenghe to boost its international footprint
- Maintaining trust in medical AI: Monitoring and managing model lifecycle
- Maintaining trust in medical AI: Monitoring and managing model lifecycle
- Eli Lilly shoots for health in new Caitlin Clark ad campaign
- Omada Health posts 42% revenue jump in Q1, joins Eli Lilly employer weight loss program
- Journalists Shed Light on Deadly Hantavirus Outbreak and a Crisis in the Nation’s ERs
- The Make America Healthy Again Movement Comes for Hospital Food
- Remarks at the Conference on Financial Market Regulation
- Dad Jokes: Remarks at the 13th Annual Conference on Financial Markets Regulation
- RFK Jr. Launches Plan To Curb Antidepressant 'Overprescription'
- AI-augmented behavioral health provider Theris launches out of stealth
- Skil-Care launches specialized healthcare product innovation program
- As new tech, AI sweeps the marketing world, Eversana Intouch’s new CEO is ‘comfortable in the gray’
- Sanford Health unveils deal to integrate Minnesota-area North Memorial Health, invest $600M
- UPDATED—Trump plans to fire FDA chief Marty Makary: report
- UPDATED—Trump plans to fire FDA chief Marty Makary: report
- Remarks at the Special Competitive Studies Project AI+ Expo
- Lawmakers, former FDA leaders and more rally behind mifepristone as Supreme Court weighs telemedicine access to abortion pill
- Plant-Based Foods May Help Lower Risk of High Blood Pressure
- The ACA exchanges dominated Q1 earnings calls. Here's what payer, health system execs had to say
- Integrated CDO capabilities reduce early development complexity
- Targeted Protein Degradation and Novel Modalities: Getting on the Frontline
- Gilead cranks up Yeztugo first-year sales forecast to $1B on 'unprecedented launch trajectory'
- Workplace safety is a top priority for 93% of healthcare leaders: Axon survey
- Capricor Therapeutics files breach-of-contract lawsuit against US partner NS Pharma
- Op-ed: It's time to make more strategic bets on AI in healthcare
- Daiichi Sankyo takes $610M profit hit linked to ADC manufacturing overbuild
- Super Shoes Might Increase Risk Of Running Injuries, Study Says
- TV, Movies Offer Flawed Depictions Of Autism, Add To Delayed Diagnosis, Study Says
- Opioid OD Survivors Have Triple Rate Of Repeat Overdoses Than Previously Estimated
- A New Medicare Option For Weight Loss Drugs: What Older Americans Should Know
- Exposure Therapy Can Successfully Ease Peanut Allergies
- Listen: A Federal Agency Is After Workers’ Health Data, and Critics Are Alarmed
- In California Governor Race, Single-Payer Is a Litmus Test. There’s Still No Way To Pay for It.
- Cruise Ship Hantavirus Outbreak Kills 3 as WHO Says Risk Is Low
- How policy, reimbursement incentives, could help healthcare address its climate footprint
- Remarks at the 13th Annual Conference on Financial Market Regulation
- New Study Suggests The Brain Can Continue Learning While In An Unconscious State
- Health Tech Weekly Rundown: Tether rolls out medical AI for phones, wearables; Medaptus launches operational ‘command center’
- Every 1,000 Steps After Surgery Cuts Complication Risk, Study Finds
- Bullying and Politics Fuel Suicide Risk for LGBTQ+ Teens and Young Adults, Survey Finds
- Head Impacts May Disrupt Gut Health Even Without Concussion
- Class of Migraine Drug, CGRP Inhibitors, Has Added Benefit: Reduced Glaucoma Risk
- States Eye Aid to Prop Up Distressed Hospitals Amid Federal Medicaid Cuts
- That Discount at the Pharmacy Counter May Pack Hidden Costs
- Trump Promised Cheaper Drugs. Some Prices Dropped. Many Others Shot Up.
- FDA Authorizes Fruit-Flavored Vapes for Adults
- Edibles + Alcohol Combo Poses Driving Risks Missed by Sobriety Tests
- VR Training Helps Autistic People Navigate Police Encounters
- Weight Loss Surgeries Fall More Than 20% As Patients Turn To GLP-1 Meds, Experts Say
Carolyn D. Gorman of the Manhattan Institute suggests a target for DoGE:
Trump Should Abolish the Federal Mental-Health Agency
SAMHSA harms those it is designed to help.By Carolyn D. Gorman - January 2, 2025
The incoming Trump administration wants to improve public safety, push back on progressive cultural politics, and cut wasteful federal spending. One way to do all three? Abolish the Substance Abuse and Mental Health Services Administration, the federal mental-health agency.
SAMHSA was created in 1992 to “reduce the impact of . . . mental illness on America’s communities” and to target services to people “most in need.” The agency has failed on both counts. People with serious mental illnesses, like schizophrenia and other psychotic disorders, remain disproportionately represented among the homeless, incarcerated, and violent-criminal populations. Mental illness has been a factor in nearly all of the deadliest mass shootings, including Sandy Hook, Viriginia Tech, Parkland, Aurora, Uvalde, El Paso, Sutherland Springs, Charleston, Oregon, Navy Yard, Binghamton, Killeen, Lewiston, Austin, Edmond, Pittsburgh, Santa Fe, Boulder, Dayton, Omaha, and Indianapolis—to name only a few.
The agency has not only failed to reduce the impact of mental illness in American life but also has undermined proven solutions by derailing resources from high-quality, intensive psychiatric treatment and advocating against involuntary commitment. Consider SAMHSA’s Protection and Advocacy (PAIMI) Program. The agency claims the program “is intended to protect and advocate for the rights” for people with serious mental illness, but in practice, it often directs funds to lawyers seeking to prevent needed hospitalizations. This can have disastrous results, as it did in 2006, when a mentally ill man named William Bruce killed his mother with a hatchet after SAMHSA-funded lawyers reportedly coached him on how to avoid involuntary treatment.
The federal mental-health agency is also a hub for progressive activism. Seemingly any left-wing priority can win SAMHSA support if proponents claim that addressing it would reduce “trauma” or improve “mental well-being.” Billions of taxpayer dollars have been hijacked for things like “non-traditional holistic support” for “LGBTQI+” families; “affirming, comprehensive care” for “unhoused LGBTQ+ youth”; employee trainings and agency publications on “Diversity, Equity, Inclusion, [and] Accessibility”; bulletins on the behavioral health effects of climate change; “Keep it Safe But Sexy” harm-reduction sessions for the “incarcerated and post-incarcerated socially disenfranchised”; and pop psychology–inspired social-emotional learning programs.
SAMHSA’s nonsense programs are only one reason to zero its budget. The agency’s own employees have ranked it one of the worst places to work in Washington. The Government Accountability Office, meantime, has found that SAMHSA makes unsubstantiated claims, hasn’t properly documented how grantees qualified for funding, and has failed to complete program reviews.
Abolishing SAMHSA would be relatively simple. Its budget is only around $7 billion, and most of its funding comes from discretionary annual appropriations that could be cut off until Congress formally puts the agency out of business. Now is a good time to act: SAMHSA’s budget has doubled in the last ten years, and it will likely continue to grow given the mental health industry’s penchant for getting policymakers to view social issues as “mental health” problems.
The first place for scissors: SAMSHA programs promoting “wellness” among the masses—usually through broad awareness, prevention, and early intervention efforts. The agency’s favored public-health-style approach makes no practical sense: we can’t prevent mental illnesses (the agency itself admits causes are unknown), while basically none of the “worried well” will develop a disabling psychiatric disorder that leads to a cycle of homelessness, arrests, and repeat hospitalizations. Schizophrenia, for example, is exceedingly rare, affecting probably less than 1 percent of the general population. Such “wellness” efforts, which expand access to care indiscriminately, do more harm than good, promoting a victim mindset, making overdiagnosis and misdiagnosis more likely, and driving mental-health-care costs higher and higher.
A handful of the agency’s programs do focus on the seriously mentally ill and are worth keeping. For example, SAMHSA supports some assisted outpatient treatment initiatives, which require a small number of people with serious mental illness who have a history of repeated arrests or hospitalizations to take medication as a condition of remaining in the community. Those programs should continue, but they can be rolled into other agencies within the Department of Health and Human Services.
SAMHSA, however, must go. The agency harms the people it is intended to help, pursues unfounded approaches to mental-health care, and serves as an incubator for progressivism. The Trump administration would do well to put an end to it.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.















